A case report of breast cancer recurrence with cystitis: the impact of immune checkpoint inhibitor therapy on the incidence of cystitis
This case highlights a rare presentation of immune-related cystitis associated with ICI therapy in recurrent breast cancer. ICIs may increase cystitis risk through immune-mediated mechanisms, although the underlying pathophysiology remains unclear, warranting further investigation.
Authors
- Jieqing Li (ORCID: https://orcid.org/0000-0002-5111-2630)
- Yingyi Lin
Institutions
- Southern Medical University (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- Immunotherapy
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/1750743x.2026.2620589
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 39.15